"egfr mutations" trang 3 - tải miễn phí từ tailieuXANH
Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations

Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations
7    97    0
SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients

SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients
7    69    0
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
11    68    0
Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: A case report

Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: A case report
6    61    0
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
9    68    0
Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China

Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China
7    49    0
Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer
10    64    0
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
6    49    0
Prediction of sensitivity to gefitinib/ erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

Prediction of sensitivity to gefitinib/ erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis
13    56    0
Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
12    40    1
Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer

Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer
9    37    1
Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: A prospective and single arm study (DANCE study)

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: A prospective and single arm study (DANCE study)
6    15    1
Epidermal growth factor receptor gene mutations in patients with lung adenocarcinoma differ by frequency and type between Uighur and Han ethnic groups in Xinjiang Autonomous Region

Epidermal growth factor receptor gene mutations in patients with lung adenocarcinoma differ by frequency and type between Uighur and Han ethnic groups in Xinjiang Autonomous Region
5    2    1
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
18    41    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.